# A Phase II Study of TollB-001 Tablets in Systemic Sclerosis

> **NCT07745725** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Toll Biotech Co. Ltd. (Beijing)** · enrollment: 36 (estimated)

## Conditions studied

- Systemic Sclerosis (SSc)

## Interventions

- **DRUG:** TollB-001 Tablet
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07745725
- **Lead sponsor:** Toll Biotech Co. Ltd. (Beijing)
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08
- **Primary completion:** 2027-10
- **Final completion:** 2028-02
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2026-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07745725

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07745725, "A Phase II Study of TollB-001 Tablets in Systemic Sclerosis". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07745725. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*